OR WAIT null SECS
June 26, 2018
A new oral delivery method developed by the Harvard John A. Paulson School of Engineering and Applied Sciences could change the way diabetics regulate blood sugar levels.
June 15, 2018
Researchers at the National Cancer Institute have developed a new approach to immunotherapy that led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
June 13, 2018
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
June 05, 2018
The agency has approved Mylan’s Fulphila (pegfilgrastim-jmdb) as the first US-approved biosimilar to Amgen’s Neulasta (pegfilgrastim) to reduce infection risk during cancer treatment.
June 04, 2018
EMA has recommended marketing authorization for Aimovig (erenumab), a new treatment for migraine.
June 01, 2018
Lonza has added four liver cell types to its hepatocytes portfolio for testing of in vitro drug models.
May 23, 2018
Right-to-Try bill sent to White House for President’s signature after passage by Congress.
Allergan will buy a potential depression treatment from Aptinyx.
May 21, 2018
The agency approved Amgen and Novartis’ Aimovig (erenumab-aooe), the first FDA-approved preventive treatment for migraine in adults.
May 16, 2018
The acquisition is expected to strengthen Novartis’ gene therapy pipeline.